Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is tetrabenazine safe and effective for suppressing chorea in Huntington's disease?

Nature Clinical Practice Neurology volume 2, pages 536–537 (2006)Cite this article

boxed-textHuntington Study Group (2006) Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 66: 366–372

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Leavitt BR and Hayden MR (2000) Huntington's disease. In Kelley's Textbook of Internal Medicine, edn 4, 2926–2928 (Ed. Humes HD) Philadelphia: Lippincott Williams and Wilkins

    Google Scholar 

  2. Frank S et al. (2004) Functional decline due to chorea in Huntington's disease. Neurology 62: A204

    Article  Google Scholar 

  3. Grimbergen YAM and Roos RAC (2003) Therapeutic options for Huntington's disease. Curr Opin Invest Drugs 4: 51–54

    CAS  Google Scholar 

  4. Barr AN et al. (1988) Serum haloperidol concentration and choreiform movements in Huntington's disease. Neurology 38: 84–88

    Article  CAS  Google Scholar 

  5. Kenney C and Jankovic J (2006) Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Rev Neurother 6: 7–17

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. neurologist in the Neurogenetics and Huntington Disease Medical Clinics of the University of British Columbia, and scientist and Director of the Transgenic Facility at the Centre for Molecular Medicine and Therapeutics in Vancouver, BC, Canada

    Blair R Leavitt

  2. full professor of Medical Genetics at the University of British Columbia, and Director of the Centre for Molecular Medicine and Therapeutics in Vancouver, BC, Canada

    Michael R Hayden

Authors
  1. Blair R Leavitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael R Hayden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael R Hayden.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leavitt, B., Hayden, M. Is tetrabenazine safe and effective for suppressing chorea in Huntington's disease?. Nat Rev Neurol 2, 536–537 (2006). https://doi.org/10.1038/ncpneuro0299

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0299

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing